Q1 Highlights: Revenue Growth and Service Gross Margin Improvement SUNNYVALE, Calif., Nov. 8, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company , announced today financial results for the first quarter of fiscal 2012 that ended September 30,
Key Milestone Reached with More Than 100 Systems Now in Use Worldwide SUNNYVALE, Calif., Oct. 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today significant momentum in global adoption of its TomoDirect treatment modality
New Technology Improves System Performance & Customer Satisfaction SUNNYVALE, Calif., Oct. 25, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the company
SUNNYVALE, Calif., Oct. 24, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its first quarter of fiscal year 2012, ended September 30, 2011 on Tuesday, November 8, 2011 after the market
Exceptional 319 Percent Revenue Growth from 2006-2010 to be Enhanced by TomoTherapy Acquisition SUNNYVALE, Calif., Oct. 19, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that it ranked 274th on Deloitte's Technology Fast
Combined Company Showcases Breadth and Depth of Treatment Capabilities, Delivering Personalized Radiation Oncology Solutions MIAMI and SUNNYVALE, Calif., Oct. 3, 2011 /PRNewswire via COMTEX/ -- American Society for Radiation Oncology (ASTRO) 53 rd Annual Meeting -- Accuray Incorporated (Nasdaq:
SUNNYVALE, Calif., Sept. 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the JMP Securities Healthcare Conference in New York on Wednesday, September 28, 2011 at 9:30 a.m.
SUNNYVALE, Calif., Sept. 23, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced details of the 2011 International Conference on TomoTherapy (ICT) , which took place September 16-17, 2011 hosted by the University of
SUNNYVALE, Calif., Sept. 21, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that Kelly Londy has joined Accuray as Senior Vice President and Chief Commercial Officer, effective October 1, 2011 .
Record Revenue Set For Quarter SUNNYVALE, Calif., Sept. 19, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the fourth quarter and fiscal year ended June 30, 2011 .
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
